Clinical Trial Update: A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and Psychotherapy [Phase 1]

View source ↗

Summary

Phase 1 study evaluating Seltorexant as an add-on to antidepressants in adolescents with major depressive disorder who had an inadequate response to SSRI therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Seltorexant (seltorexant)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major | Phase 1 | Status: TERMINATED